docetaxel anhydrous has been researched along with Glioblastoma in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.69) | 18.2507 |
| 2000's | 2 (7.69) | 29.6817 |
| 2010's | 13 (50.00) | 24.3611 |
| 2020's | 9 (34.62) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, XB; Huang, S; Li, YJ; Luo, S; Wang, J; Wu, JY; Xiang, DX | 1 |
| Barretto-de-Souza, L; Chorilli, M; Crestani, CC; Delbone Figueiredo, I; Di Filippo, LD; Hofstätter Azambuja, J; Hugo Sousa Araújo, V; Isler Mancuso, R; Lobato Duarte, J; Martins Baviera, A; Miguel Sábio, R; Sasso-Cerri, E; Tavares Luiz, M; Teresinha Ollala Saad, S | 1 |
| Decuzzi, P; Di Mascolo, D; Felici, A; Goldoni, L; Lisa Palange, A; Schlich, M | 1 |
| Araújo, M; Dias, S; Marques-Magalhães, Â; Martins, C; Moreira-Barbosa, C; Oliveira, MJ; Pacheco, C; Sarmento, B | 1 |
| Chang, S; Chen, L; Cui, M; Gao, Z; Huang, W; Jin, M; Liu, C; Liu, Y; Quan, X; Wan, H; Wang, S; Wu, H; Zhao, H | 1 |
| Fu, Z; Hu, J; Jiang, Q; Jiang, Y; Mao, K; Mao, W; Sun, H | 1 |
| Decuzzi, P; Di Mascolo, D; Guerriero, I; Palange, AL; Pesce, C; Spanò, R | 1 |
| Chew, SA; Ding, MH; Hasbum, A; Jr, JAA; Levy, A; Quintanilla, J | 1 |
| Abriata, JP; Chorilli, M; Emery, FDS; Luiz, MT; Marchetti, JM; Tofani, LB; Vaidergorn, MM; Viegas, JSR | 1 |
| Gora, RH; Gudem, S; Kadari, A; Kolapalli, VRM; Kulhari, H; Pooja, D; Sistla, R | 1 |
| Jeong, TH; Kang, JH; Ko, YT; Ramalingam, P; Turabee, MH | 1 |
| Altshuler, D; Castro, MG; Doherty, R; Edwards, M; Kadiyala, P; Kamran, N; Kuai, R; Li, D; Lowenstein, PR; Moon, JJ; Nuñez, FM; Schwendeman, A; Yu, M | 1 |
| Ataizi, ZS; Braidy, N; Ertilav, K; Nazıroğlu, M | 1 |
| Åslund, AKO; Bjerkvig, R; Borgos, SE; Davies, CL; Miletic, H; Mørch, Y; Snipstad, S; Sulheim, E | 1 |
| Chen, H; Chuan, D; Fan, R; Guo, G; Han, B; Hou, H; Tong, A; Xu, J; Zhang, X; Zhou, L | 1 |
| Cao, S; Gao, H; Jiang, X; Pang, Z; Yang, Z; Zhang, S | 1 |
| Bu, ZF; Cao, PC; Li, AJ; Liu, GD; Liu, WS; Zheng, YH | 1 |
| Gao, H; He, Q; Liu, Y; Shi, K; Zhang, Q; Zhou, J; Zong, T | 1 |
| Guo, F; Hao, Y; Ji, R; Ren, X; Shi, J; Sun, S; Wang, L; Zhang, B; Zhang, H; Zhang, Y; Zhang, Z; Zheng, C | 1 |
| Chen, PP; Fan, ZL; Jin, BH; Lu, CT; Mao, KL; Shen, BX; Xiao, J; Xu, HL; Xu, J; Yang, JJ; Zhao, YZ; ZhuGe, DL | 1 |
| Gao, W; Liu, YJ; Pang, N; Qi, XR; Yang, ZZ | 1 |
| Jon, S; Kim, H; Lee, E; Lee, IH | 1 |
| Gajbhiye, V; Jain, NK | 1 |
| Dicker, AP; Grant, DS; Williams, TL; Zahaczewsky, M | 1 |
| Georgoulias, V; Giatromanolaki, A; Kakolyris, S; Koukourakis, MI; Schiza, S | 1 |
| Boucher, Y; Brekken, C; Griffon-Etienne, G; Jain, RK; Suit, HD | 1 |
1 review(s) available for docetaxel anhydrous and Glioblastoma
| Article | Year |
|---|---|
Strategies to better treat glioblastoma: antiangiogenic agents and endothelial cell targeting agents.
Topics: Angiogenesis Inhibitors; Biocompatible Materials; Brain Neoplasms; Combined Modality Therapy; Docetaxel; Glioblastoma; Humans; Minocycline; Nucleic Acids; Small Molecule Libraries | 2021 |
1 trial(s) available for docetaxel anhydrous and Glioblastoma
| Article | Year |
|---|---|
Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Docetaxel; Dose Fractionation, Radiation; Drug Administration Schedule; Feasibility Studies; Female; Glioblastoma; Humans; Lung Neoplasms; Lymphocytes; Lymphopenia; Male; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Pelvic Neoplasms; Radiation-Sensitizing Agents; Radiotherapy; Survival Analysis; Taxoids; Treatment Outcome | 1999 |
24 other study(ies) available for docetaxel anhydrous and Glioblastoma
| Article | Year |
|---|---|
Multifunctional exosome-mimetics for targeted anti-glioblastoma therapy by manipulating protein corona.
Topics: Animals; Antineoplastic Agents; Biomimetic Materials; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Delivery Systems; Exosomes; Glioblastoma; Humans; Mice; Protein Corona | 2021 |
Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression.
Topics: Animals; Antineoplastic Agents; Bevacizumab; Cell Line, Tumor; Docetaxel; Drug Carriers; Glioblastoma; Leukocytes, Mononuclear; Lipids; Nanoparticles; Particle Size; Rats; Tissue Distribution | 2022 |
Boosting the therapeutic efficacy of discoidal nanoconstructs against glioblastoma with rationally designed PEG-Docetaxel conjugates.
Topics: Animals; Antineoplastic Agents; Docetaxel; Glioblastoma; Mice; Nanoparticles; Oleic Acid; Polyethylene Glycols; Taxoids | 2022 |
Glioblastoma immuno-endothelial multicellular microtissue as a 3D in vitro evaluation tool of anti-cancer nano-therapeutics.
Topics: Brain Neoplasms; Cell Line, Tumor; Cytokines; Docetaxel; Endothelial Cells; Glioblastoma; Humans; Tumor Microenvironment | 2023 |
Combined Biomimetic MOF-RVG15 Nanoformulation Efficient Over BBB for Effective Anti-Glioblastoma in Mice Model.
Topics: Animals; Biomimetics; Blood-Brain Barrier; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Glioblastoma; Glioma; Mice; Nanoparticles; Peptides; Tissue Distribution | 2022 |
Ultra-small micelles together with UTMD enhanced the therapeutic effect of docetaxel on Glioblastoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Docetaxel; Glioblastoma; Micelles; Microbubbles; Rats | 2023 |
μMESH-Enabled Sustained Delivery of Molecular and Nanoformulated Drugs for Glioblastoma Treatment.
Topics: Animals; Cell Line, Tumor; Docetaxel; Glioblastoma; Nanoparticles; Paclitaxel; Pharmaceutical Preparations; Polymers; Polyvinyl Alcohol | 2023 |
Docetaxel-loaded folate-modified TPGS-transfersomes for glioblastoma multiforme treatment.
Topics: Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Carriers; Folic Acid; Glioblastoma; Humans; Nanoparticles; Vitamin E | 2021 |
Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Drug Design; Glioblastoma; Glioma; Humans; Lipids; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Peptides; Survival Rate; Tissue Distribution | 2018 |
N,N,N-trimethyl chitosan embedded in situ Pluronic F127 hydrogel for the treatment of brain tumor.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chitosan; Docetaxel; Drug Carriers; Drug Liberation; Glioblastoma; Humans; Hydrogels; Hydrogen-Ion Concentration; Male; Mice, Inbred BALB C; Mice, Nude; Poloxamer; Taxoids | 2019 |
High-Density Lipoprotein-Mimicking Nanodiscs for Chemo-immunotherapy against Glioblastoma Multiforme.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Docetaxel; Drug Delivery Systems; Female; Flow Cytometry; Glioblastoma; Humans; Immunohistochemistry; Immunotherapy; Lipoproteins, HDL; Lomustine; Mice; Models, Biological; Paclitaxel; Rats; T-Lymphocytes | 2019 |
Selenium Enhances the Apoptotic Efficacy of Docetaxel Through Activation of TRPM2 Channel in DBTRG Glioblastoma Cells.
Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Calcium; Cell Line, Tumor; Cell Survival; Docetaxel; Glioblastoma; Humans; Membrane Potential, Mitochondrial; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Reactive Oxygen Species; Selenium; TRPM Cation Channels | 2019 |
Therapeutic Effect of Cabazitaxel and Blood-Brain Barrier opening in a Patient-Derived Glioblastoma Model.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Docetaxel; Female; Glioblastoma; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Neoplasms, Experimental; Taxoids; Xenograft Model Antitumor Assays | 2019 |
Development of a hybrid nanocarrier-recognizing tumor vasculature and penetrating the BBB for glioblastoma multi-targeting therapy.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Docetaxel; Drug Carriers; Glioblastoma; Hyaluronic Acid; Male; Mice; Mice, Nude; Nanoparticles; NIH 3T3 Cells; Peptides; Rats; Rats, Sprague-Dawley; Xenograft Model Antitumor Assays | 2019 |
In vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Transport; Brain Neoplasms; Cell Line, Tumor; Coumarins; Docetaxel; Drug Delivery Systems; Glioblastoma; Humans; Interleukin-13; Male; Mice, Inbred BALB C; Nanoparticles; Peptides; Taxoids; Thiazoles | 2014 |
Efficient delivery of docetaxel for the treatment of brain tumors by cyclic RGD-tagged polymeric micelles.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Docetaxel; Drug Carriers; Drug Delivery Systems; Drug Liberation; Glioblastoma; Humans; Mice; Micelles; Particle Size; Peptides, Cyclic; Polyethylene Glycols; Polymers; Spheroids, Cellular; Taxoids; Tumor Burden; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
Arginine-Glycine-Aspartic Acid-Modified Lipid-Polymer Hybrid Nanoparticles for Docetaxel Delivery in Glioblastoma Multiforme.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Diffusion; Docetaxel; Glioblastoma; Lipids; Nanocapsules; Nanocomposites; Oligopeptides; Polymers; Rats; Rats, Sprague-Dawley; Survival Rate; Taxoids; Treatment Outcome | 2015 |
The tumor-targeting core-shell structured DTX-loaded PLGA@Au nanoparticles for chemo-photothermal therapy and X-ray imaging.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chlorides; Contrast Media; Docetaxel; Drug Carriers; Drug Compounding; Glioblastoma; Gold Compounds; Humans; Injections, Intravenous; Lactic Acid; Lasers; Metal Nanoparticles; Mice, Inbred BALB C; Mice, Nude; Peptides; Photochemotherapy; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Taxoids; Temperature; Theranostic Nanomedicine; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
An injectable acellular matrix scaffold with absorbable permeable nanoparticles improves the therapeutic effects of docetaxel on glioblastoma.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cell-Free System; Delayed-Action Preparations; Docetaxel; Drug Synergism; Emulsions; Extracellular Matrix; Glioblastoma; Injections, Intralesional; Male; Permeability; Rats; Rats, Sprague-Dawley; Taxoids; Treatment Outcome | 2016 |
Delivering siRNA and Chemotherapeutic Molecules Across BBB and BTB for Intracranial Glioblastoma Therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Docetaxel; Down-Regulation; Gene Silencing; Glioblastoma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liposomes; Mice; Peptides; RNA, Small Interfering; Taxoids; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2017 |
In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
Topics: Adhesiveness; Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Docetaxel; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Female; Glioblastoma; Half-Life; Humans; Inhibitory Concentration 50; Injections, Intravenous; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Prodrugs; Solubility; Taxoids; Tumor Burden; Xenograft Model Antitumor Assays | 2009 |
The treatment of Glioblastoma Xenografts by surfactant conjugated dendritic nanoconjugates.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dendrimers; Docetaxel; Glioblastoma; Humans; Male; Nanoconjugates; Polysorbates; Rats; Surface-Active Agents; Taxoids; Xenograft Model Antitumor Assays | 2011 |
Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere).
Topics: Angiogenesis Inhibitors; Animals; Aorta; Apoptosis; Capillaries; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Cell Division; Cells, Cultured; Chemotaxis; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endothelium, Vascular; Fibrosarcoma; Glioblastoma; Humans; Lung Neoplasms; Male; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Rats; Taxoids; Tumor Cells, Cultured; Umbilical Veins; Xenograft Model Antitumor Assays | 2003 |
Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blood Vessels; Brain Neoplasms; Docetaxel; Female; Glioblastoma; Humans; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Paclitaxel; Pressure; Sarcoma, Experimental; Specific Pathogen-Free Organisms; Taxoids; Tumor Cells, Cultured | 1999 |